Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403